B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • RnM3784338
  • |
  • 26 September, 2019
  • |
  • 147 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

Make an enquiry before buying this Report



Purchase this Report

$10,995.00
$21,990.00
$32,985.00
8,499.14
16,998.27
25,497.41
10,236.35
20,472.69
30,709.04
1,678,826.55
3,357,653.10
5,036,479.65
927,978.00
1,855,956.00
2,783,934.00
Credit card Logo